These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 29289556)

  • 41. Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder.
    Suchting R; Yoon JH; Miguel GGS; Green CE; Weaver MF; Vincent JN; Fries GR; Schmitz JM; Lane SD
    Brain Res; 2020 Mar; 1731():146359. PubMed ID: 31374218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.
    Yin J; Mobarec JC; Kolb P; Rosenbaum DM
    Nature; 2015 Mar; 519(7542):247-50. PubMed ID: 25533960
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
    Keenan RJ; Daykin H; Metha J; Cornthwaite-Duncan L; Wright DK; Clarke K; Oberrauch S; Brian M; Stephenson S; Nowell CJ; Allocca G; Barnham KJ; Hoyer D; Jacobson LH
    Br J Pharmacol; 2024 Jan; 181(1):87-106. PubMed ID: 37553894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suvorexant for the treatment of insomnia.
    Jacobson LH; Callander GE; Hoyer D
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):711-30. PubMed ID: 25318834
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.
    Yin J; Babaoglu K; Brautigam CA; Clark L; Shao Z; Scheuermann TH; Harrell CM; Gotter AL; Roecker AJ; Winrow CJ; Renger JJ; Coleman PJ; Rosenbaum DM
    Nat Struct Mol Biol; 2016 Apr; 23(4):293-9. PubMed ID: 26950369
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.
    Muehlan C; Vaillant C; Zenklusen I; Kraehenbuehl S; Dingemanse J
    Expert Opin Drug Metab Toxicol; 2020 Nov; 16(11):1063-1078. PubMed ID: 32901578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect.
    Simmons SJ; Gentile TA
    Brain Res; 2020 Mar; 1731():146164. PubMed ID: 30796894
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems.
    Kaplan GB; Lakis GA; Zhoba H
    Brain Res Bull; 2022 Aug; 186():106-122. PubMed ID: 35618150
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addition of Suvorexant to Ramelteon Therapy for Improved Sleep Quality with Reduced Delirium Risk in Acute Stroke Patients.
    Kawada K; Ohta T; Tanaka K; Miyamura M; Tanaka S
    J Stroke Cerebrovasc Dis; 2019 Jan; 28(1):142-148. PubMed ID: 30322756
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescription Drugs Used in Insomnia.
    Dujardin S; Pijpers A; Pevernagie D
    Sleep Med Clin; 2020 Jun; 15(2):133-145. PubMed ID: 32386689
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suvorexant: a dual orexin receptor antagonist for the treatment of sleep onset and sleep maintenance insomnia.
    Patel KV; Aspesi AV; Evoy KE
    Ann Pharmacother; 2015 Apr; 49(4):477-83. PubMed ID: 25667197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Orexin Plays a Role in Growth Impediment Induced by Obstructive Sleep Breathing in Rats.
    Tarasiuk A; Levi A; Assadi MH; Troib A; Segev Y
    Sleep; 2016 Apr; 39(4):887-97. PubMed ID: 26943473
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant.
    Herring WJ; Snyder E; Budd K; Hutzelmann J; Snavely D; Liu K; Lines C; Roth T; Michelson D
    Neurology; 2012 Dec; 79(23):2265-74. PubMed ID: 23197752
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orexin contributes to eupnea within a critical period of postnatal development.
    Spinieli RL; Ben Musa R; Kielhofner J; Cornelius-Green J; Cummings KJ
    Am J Physiol Regul Integr Comp Physiol; 2021 Oct; 321(4):R558-R571. PubMed ID: 34405704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Crystal Structures of Human Orexin 2 Receptor Bound to the Subtype-Selective Antagonist EMPA.
    Suno R; Kimura KT; Nakane T; Yamashita K; Wang J; Fujiwara T; Yamanaka Y; Im D; Horita S; Tsujimoto H; Tawaramoto MS; Hirokawa T; Nango E; Tono K; Kameshima T; Hatsui T; Joti Y; Yabashi M; Shimamoto K; Yamamoto M; Rosenbaum DM; Iwata S; Shimamura T; Kobayashi T
    Structure; 2018 Jan; 26(1):7-19.e5. PubMed ID: 29225076
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soporific effect of modified Suanzaoren Decoction on mice models of insomnia by regulating Orexin-A and HPA axis homeostasis.
    Dong YJ; Jiang NH; Zhan LH; Teng X; Fang X; Lin MQ; Xie ZY; Luo R; Li LZ; Li B; Zhang BB; Lv GY; Chen SH
    Biomed Pharmacother; 2021 Nov; 143():112141. PubMed ID: 34509822
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist.
    Winrow CJ; Gotter AL; Cox CD; Doran SM; Tannenbaum PL; Breslin MJ; Garson SL; Fox SV; Harrell CM; Stevens J; Reiss DR; Cui D; Coleman PJ; Renger JJ
    J Neurogenet; 2011 Mar; 25(1-2):52-61. PubMed ID: 21473737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing survey.
    Sano H; Asai Y; Miyazaki M; Iwakura M; Maeda Y; Hara M
    Expert Opin Drug Saf; 2019 Nov; 18(11):1109-1118. PubMed ID: 31478753
    [No Abstract]   [Full Text] [Related]  

  • 59. Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.
    Herring WJ; Connor KM; Ivgy-May N; Snyder E; Liu K; Snavely DB; Krystal AD; Walsh JK; Benca RM; Rosenberg R; Sangal RB; Budd K; Hutzelmann J; Leibensperger H; Froman S; Lines C; Roth T; Michelson D
    Biol Psychiatry; 2016 Jan; 79(2):136-48. PubMed ID: 25526970
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Orexin in Respiratory and Autonomic Regulation, Health and Diseases.
    Barnett S; Li A
    Compr Physiol; 2020 Mar; 10(2):345-363. PubMed ID: 32163209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.